Drug Policy Monitor | 46 Available

Drug Policy Monitor examines the value of pharmaceuticals within America’s health care system. This newsletter looks at a variety of topics including drug access and reimbursement in Medicare and Medicaid programs.

As lawmakers consider making it easier to import foreign drugs nearly two-thirds of Americans lack confidence in foreign manufactured prescription drugs

Nearly two-thirds of Americans lack confidence in foreign manufactured prescription drugs. Despite this, lawmakers are considering making it easier to import foreign drugs. Of particular concern are medicines purchased on the internet – US citizens cannot be certain where the product is coming from, if it is real, safe and effective or who and where the drug was manufactured.

read more
September 20, 2007


Institutional, physician and clinical services accounts for nearly 70% of U.S. personal health spending growth over the past 5 years.

According to the Centers for Medicare and Medicaid Services, personal health care expenditures, from 2002 to 2007, are projected to grow by 41 per cent. Institutional, physician and clinical services accounts for nearly 70% of us personal health spending growth over the past 5 years.

read more
July 22, 2007


Encouraging consumers to import foreign drugs puts american patients at risk

Patients need to have confidence in the quality, safety and effectiveness of their medicines. In developed countries, governments enact laws and regulations that provide stringent safeguards for drug approval, manufacturing, labelling and distribution.

read more
June 24, 2007


Les aînés américains ont un meilleur accès aux médicaments sur ordonnance dans le cadre du régime Medicare Part D que les aînés canadiens sous les régimes d’assurance-médicaments subventionnés par l’État.

Grâce au régime Medicare Part D, aux États-Unis, l’accès aux régimes d’assurance-médicaments subventionnés par l’État a surpassé celui au Canada.

read more
March 04, 2007


American seniors have better access to prescription drugs under Medicare Part D plans than Canadian seniors under Canadian publicly funded drug plans.

Drug benefits under Medicare Part D provide American seniors better access to prescription drugs than Canadian seniors have under the restrictive drug benefit programs available to seniors in Canada.

read more
March 05, 2007


Copyright © 2005 Ward Advocacy Communications Inc